Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.
about
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug RepositioningDevelopment and Validation of a Novel Leishmania donovani Screening Cascade for High-Throughput Screening Using a Novel Axenic Assay with High Predictivity of Leishmanicidal Intracellular Activity.Repurposing of the Open Access Malaria Box for Kinetoplastid Diseases Identifies Novel Active Scaffolds against Trypanosomatids.Identification and Characterization of FTY720 for the Treatment of Human African Trypanosomiasis.Oral Efficacy of Apigenin against Cutaneous Leishmaniasis: Involvement of Reactive Oxygen Species and Autophagy as a Mechanism of Action.Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosineA Replicative In Vitro Assay for Drug Discovery against Leishmania donovaniYeast as a potential vehicle for neglected tropical disease drug discovery.Novel drug discovery for Chagas disease.Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need.Chemotherapy of leishmaniasis: present challenges.Interactions between 4-aminoquinoline and heme: Promising mechanism against Trypanosoma cruzi.Drug target identification using a trypanosome overexpression library.Screening a Natural Product-Based Library against Kinetoplastid Parasites.The Trypanocidal Effect of Novel Quinolines: In vitro And In vivo Studies.Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani.Discovery of novel, orally bioavailable, antileishmanial compounds using phenotypic screening.Antitrypanosomal and antileishmanial activity of prenyl-1,2,3-triazoles.Development of (6 R)-2-Nitro-6-[4-(trifluoromethoxy)phenoxy]-6,7-dihydro-5 H-imidazo[2,1- b][1,3]oxazine (DNDI-8219): A New Lead for Visceral Leishmaniasis.Innovation in neglected tropical disease drug discovery and development.Neolignans isolated from twigs of Ness & Mart (Lauraceae) displayed in vitro antileishmanial activityRepurposing Strategy of Atorvastatin against Trypanosoma cruzi: Monotherapy and Combined Therapy with Benznidazole Exhibit Synergistic Trypanocidal ActivityCurrent Screening Methodologies in Drug Discovery for Selected Human Diseases
P2860
Q28547217-4052928D-1AC7-4D29-AD47-47E25D9F50CEQ28548536-7C23C50B-F499-46E7-9579-7EC61EB1E289Q30487641-92DD5B19-28BD-4997-9482-3EE578287467Q35868574-B044A379-7569-43AE-9605-3D3EA720ABF4Q35919447-437F37C6-EA4E-48B3-8AE0-9E5D9B95E5DCQ36380098-F0E267CA-08DF-4637-8AAB-23CE7B019912Q36933516-1E1E52BC-8874-4C73-A0E4-B27BEBB9CE05Q38239749-B893C4E4-6A6D-4ABD-B3DF-CE0810A4B300Q38770142-CB1E6CC5-17BC-46EE-A8CE-529665AED1C5Q39003990-8D1C6CCA-4077-4BA1-9A27-7EC8856DEDB5Q39011875-C3662256-79FA-4295-B5C3-3E0AD50C27A8Q39165581-24F8BADA-C261-47D2-8979-5190EC579ED7Q42114206-006B5421-94F0-41E0-9EB7-A79DE5000205Q42796077-20AFA37B-0E97-40EF-ACEF-178371C59A1EQ46248416-30EC75BE-B74E-4059-9C13-8E79ADD67B13Q47132474-58A6A900-5D23-4606-AB8A-B74B98E37FF6Q48330948-0723BAAD-87BF-4A13-AC9A-897972DE3072Q49376507-D4C05625-3B2E-45A8-9E72-CBFC1B0498CCQ51730628-1D3FE3A5-0390-4050-B352-5C6814D917C9Q55459515-A40E47AA-7BFB-4763-833E-C8AEE72C9E13Q57068498-06B07BE1-5FEB-4134-B724-91F5ED09F5E6Q57167324-0F82D241-00AF-47DA-9D19-7B5B384FEF07Q57169512-36E99D82-A719-417C-8F23-5438B79F7C3C
P2860
Screening strategies to identify new chemical diversity for drug development to treat kinetoplastid infections.
description
2013 nî lūn-bûn
@nan
2013 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Screening strategies to identi ...... reat kinetoplastid infections.
@ast
Screening strategies to identi ...... reat kinetoplastid infections.
@en
Screening strategies to identi ...... reat kinetoplastid infections.
@nl
type
label
Screening strategies to identi ...... reat kinetoplastid infections.
@ast
Screening strategies to identi ...... reat kinetoplastid infections.
@en
Screening strategies to identi ...... reat kinetoplastid infections.
@nl
prefLabel
Screening strategies to identi ...... reat kinetoplastid infections.
@ast
Screening strategies to identi ...... reat kinetoplastid infections.
@en
Screening strategies to identi ...... reat kinetoplastid infections.
@nl
P2860
P1433
P1476
Screening strategies to identi ...... reat kinetoplastid infections.
@en
P2093
Jean-Robert Ioset
P2860
P304
P356
10.1017/S003118201300142X
P577
2013-08-28T00:00:00Z